Beta Cat Pharmaceuticals, Inc.
3Patents
3Active
3Granted
44Portfolio score
Filing activity: Nov 6, 2012 → Aug 8, 2017
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9725473B2 | Anthracene-9, 10-dione dioxime compound prodrugs and their uses | Chemistry; Metallurgy | 6 | Active |
| US9238030B2 | Methods for treatment of diseases and disorders related to transducin β-like protein 1 (TBL1) activity, including myeloproliferative neoplasia and chronic myeloid leukemia | Human Necessities | 0 | Active |
| US9963475B2 | Anthracene-9, 10-dione dioxime compound prodrugs and their uses | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.